First Solar Inc. (FSLR) Financials Nov 18, 2014, 6:56

New Post Public Reply Private Reply Replies (0) Message Board
Hirata
First Solar Inc. (FSLR) Financials Nov 18, 2014, 6:56 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for First Solar Inc.


Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.09B 2.54B 2.75B 3.38B 3.29B
Cost of Goods Sold (COGS) incl. D&A 1.02B 1.37B 1.79B 2.52B 2.44B
COGS excluding D&A 893.83M 1.22B 1.56B 2.25B 2.2B
Depreciation & Amortization Expense 129.63M 156.09M 235.23M 265.4M 238.8M
Depreciation 124.6M 150.5M 230.2M 263.3M 237.9M
Amortization of Intangibles 5.03M 5.59M 5.03M 2.1M 900,000
Gross Income 1.06B 1.16B 959.32M 860.82M 848.08M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 359.47M 428.74M 586.68M 421.21M 407.33M
Research & Development 78.16M 94.8M 140.52M 132.46M 134.3M
Other SG&A 281.31M 333.95M 446.16M 288.75M 273.03M
Other Operating Expense 0 0 0 0 0
Unusual Expense 16.45M (18,000) 457.41M 464.63M 79.27M
EBIT after Unusual Expense (16.45M) 18,000 (457.41M) (464.63M) (79.27M)
Non Operating Income/Expense (10.09M) 13.7M 17.77M (10.6M) 627,000
Non-Operating Interest Income 9.74M 14.38M 13.39M 12.82M 16.75M
Equity in Affiliates (Pretax) - - - - 0
Interest Expense 2.27M 6,000 100,000 17.01M 639,000
Gross Interest Expense 8.91M 10.07M 15.35M 27.31M 10.46M
Interest Capitalized 6.64M 10.06M 15.25M 10.3M 9.82M
Pretax Income 686.31M 762.08M (53.71M) (39.8M) 378.22M
Income Tax 46.18M 97.88M (14.22M) 56.53M 25.18M
Income Tax - Current Domestic 21M 93.42M 118.24M 36.8M 45.27M
Income Tax - Current Foreign 60.21M 62.49M 23.05M 6.8M 788,000
Income Tax - Deferred Domestic (40.03M) (61.25M) (148.28M) 4.41M (9.79M)
Income Tax - Deferred Foreign 5M 3.21M (7.22M) 8.53M (11.09M)
Income Tax Credits - - - - 0
Equity in Affiliates - - - - 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 640.14M 664.2M (39.49M) (96.34M) 353.04M
Minority Interest Expense 0 0 0 0 0
Net Income 640.14M 664.2M (39.49M) (96.34M) 353.04M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 640.14M 664.2M (39.49M) (96.34M) 353.04M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 640.14M 664.2M (39.49M) (96.34M) 353.04M
EPS (Basic) 7.67 7.82 (0.46) (1.11) 3.77
Basic Shares Outstanding 83.5M 84.89M 86.07M 86.86M 93.7M
EPS (Diluted) 7.53 7.68 (0.46) (1.11) 3.70
Diluted Shares Outstanding 85.04M 86.49M 86.07M 86.86M 95.47M
EBITDA 835.02M 890.09M 607.87M 705.01M 679.55M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding Rollins' Current Market Position and Outlook

Updated Category News Views 226

Analyzing Rollins Inc.'s Stock Performance As we look at the current performance of Rollins Inc. (NYSE: ROL), the shares are trading around $55.73, reflecting a decrease of 1.24% in the recent session. While the stock has dipped by 3.81% over the past month, it has impressively increased by 10.91% year-over-year. This presents a curious juxtaposition of short-term...

Continue Reading
Silver One Reports Major Mineral Resource Estimate for Candelaria

Updated Category News Views 199

Candelaria Project Mineral Resource Estimate Silver One Resources Inc. (OTCQX: SLVRF) has made a significant announcement regarding the completion of a mineral resource estimate for the Candelaria Project. This estimate is prepared in accordance with the National Instrument 43-101, ensuring that the resources are assessed with high standards of transparency and accuracy....

Continue Reading
Investors Alert: Zynex (ZYXI) Faces Serious Legal Scrutiny

Updated Category News Views 197

Legal Investigation into Zynex, Inc. The Law Offices of Frank R. Cruz have announced a crucial investigation regarding Zynex, Inc. (ZYXI) focused on potential violations of federal securities laws. This investigation comes as a response to significant concerns raised about the company's recent financial disclosures and their implications for investors. Understanding the...

Continue Reading
Understanding Rentokil Initial's Stock Valuation Insights

Updated Category News Views 100

Assessing Rentokil Initial's Stock Performance In the current trading session, Rentokil Initial Inc. (NYSE: RTO) shares are priced at $26.42, witnessing a notable increase of 1.46%. Over the past month, the stock has gained 1.40%, though it has faced a decline of 7.78% in the last year. This fluctuation raises questions among shareholders regarding its valuation, despite...

Continue Reading
Innovative Insights on Efzofitimod from aTyr Pharma's Recent Conference

Updated Category News Views 177

aTyr Pharma Highlights Efzofitimod at Key Conference At a significant scientific gathering, aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology firm known for its innovative therapeutic approaches, shared compelling data concerning efzofitimod. This presentation underlined important insights about the treatment of pulmonary sarcoidosis. The conference, which...

Continue Reading